niryuu/sni-each-converted huggingface dataset:
Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
Output: non-adverse drug event
We report for the first time on a patient who had isolated aspergillosis of the small bowel after autologous stem cell transplantation.
Output: non-adverse drug event
This report presents a patient with membranoproliferative glomerulonephritis (MPGN) who developed KS following treatment with long-term medium dose glucocorticoid and short-term additional immunosuppressives.
Output: non-adverse drug event
As compared with an expected number of 0.04 cases of acute myeloblastic leukemia based on patient-years, the observed seven cases correspond to a 175-times increased risk.
Output: non-adverse drug event
A 55-year-old woman with systemic lupus erythematosus was admitted with fever of unknown origin.
Output: non-adverse drug event
Comparing baseline CGI with that obtained on the date of last evaluation for each patient, a significant improvement in clinical assessment of severity of illness was obtained for the total group (Wilcoxon signed rank test, p < 0.0001).
Output: non-adverse drug event
The presented case illustrates that a combined overdose of tricyclic antidepressants and neuroleptics enhances the possible toxic effects of each drug and especially the risk for adverse cardiac events.
Output: non-adverse drug event
On day 15 of cycle 1, he reported progressive worsening of weakness and fatigue, and melena.
Output: non-adverse drug event
CONCLUSION: This case provides support for the practice of obtaining routine fungal cultures of donor rims at the time of corneal transplantation and for the implementation of prophylactic antifungal therapy in culture-positive cases.
Output: non-adverse drug event
Despite treatment in the intensive care unit, the woman died on the sixth day after admission.
Output: non-adverse drug event
This case is the first report in which RLS augmentation is shown to be characterized by motor hyperkinesias paralleling levodopa plasma pharmacokinetic profile.
Output: non-adverse drug event
Miconazole a new antifungal agent was used with dramatic response.
Output: non-adverse drug event
Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Output: non-adverse drug event
The acyclovir levels measured by radioimmunoassay were related to the level of consciousness.
Output: non-adverse drug event
Clinical and electrodiagnostic findings are discussed in detail and a brief review of the literature is presented.
Output: non-adverse drug event
Discontinuation of etanercept led to control of heart function.
Output: non-adverse drug event
The only recent change in their treatment was the introduction or increased dosage of zonisamide.
Output: non-adverse drug event
RESULTS: [1] Mucin secretion was increased by 63% over the controls in the VVR in vitro group (p < 0.01).
Output: non-adverse drug event
Histological examination of a skin biopsy was consistent with leucocytoclastic vasculitis.
Output: non-adverse drug event
Acute spontaneous TLS is rare, and it has been described in leukemia and lymphoma and in some patients with solid tumors prior to institution of therapy.
Output: non-adverse drug event
Significant deteriorations were demonstrated in cognitive (p = 0.04) and social functions (p = 0.04), compared with assessment of pre-morbid function.
Output: non-adverse drug event
Clinicians should, therefore, consider AI in patients with spinal cord injury receiving glucocorticoids, a population in whom it may otherwise go undiagnosed and untreated.
Output: non-adverse drug event
About three weeks into the therapy regimen, he complained of severe retrosternal chest oppression.
Output: non-adverse drug event
The patient received OLT because of end-stage primary biliary cirrhosis and was found to have de novo HBV infection 3 months later.
Output: non-adverse drug event
We conclude that symptoms of a postdural puncture headache can mimic those of postpartum preeclampsia.
Output: non-adverse drug event
A multicentric retrospective pilot study was undertaken to detect GCV-resistance through mutations within the UL97 gene in renal transplant recipients who experienced active HCMV infection and received valacyclovir prophylaxis.
Output: non-adverse drug event
We describe an infant who developed juvenile glaucoma with buphthalmos while receiving systemic steroid treatment.
Output: non-adverse drug event
Clinical resolution was achieved with granulocyte colony-stimulating factor and amphotericin B administration.
Output: non-adverse drug event
Their criticisms also differed from a third criticism contained in the article as well as the protocol being advocated in the article, thus contravening the claim that there is one prescribed protocol which must be followed.
Output: non-adverse drug event
PURPOSE: We report a case of a patient who developed a postoperative anterior spinal artery syndrome that was masked by the use of epidural analgesia.
Output: non-adverse drug event
G-banding analyses of bone marrow cells had repeatedly demonstrated normal male karyotype before this event, but t(9;22)(q34;q11) was demonstrated after the event.
Output: non-adverse drug event
Short cardiopulmonary resuscitation restored spontaneous circulation and the patient recovered completely.
Output: non-adverse drug event
The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children.
Output: non-adverse drug event
During a second FAB infusion (400 mg) the patient reverted to regular AV-conduction.
Output: non-adverse drug event
Diffuse pulmonary infiltrates in immunocompromised patients.
Output: non-adverse drug event
Pentavalent antimonial drugs used for the treatment of leishmaniasis have been associated with sudden deaths, probably due to the development of ventricular tachyarrhythmias.
Output: non-adverse drug event
Apart from some minor discomfort at the site of operation, no side effects were noted.
Output: non-adverse drug event
The patient developed tonic-clonic seizures, which resolved with diazepam and midazolam therapy.
Output: non-adverse drug event
The treatment was continued for 6 months without recurrence of the symptoms.
Output: non-adverse drug event
Thrombolytic therapy is being used with increasing frequency to treat acute myocardial infarction (MI).
Output: non-adverse drug event
This review provides an evidence and experience-based approach to the preventive treatment of migraine.
Output: non-adverse drug event
That feature underscores the heterogeneity of the FAD clinical phenotype.
Output: non-adverse drug event
Persistent corneal erosion secondary to tarsal adrenochrome deposit.
Output: non-adverse drug event
This is a rare complication of bypass surgery and may be a cause of recurrent angina postoperatively due to coronary artery steal.
Output: non-adverse drug event
Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism.
Output: non-adverse drug event
Cytomegalovirus is a common infection worldwide and in the immunocompromised individual it can be a major cause of morbidity and mortality.
Output: non-adverse drug event
Spontaneous regression of the lesions was noted after discontinuation of the treatment.
Output: non-adverse drug event
This avoids the need for bronchoscopic examination or transfer of the patient for computed tomography.
Output: non-adverse drug event
The decedent was also prescribed tramadol, gabapentin, cetirizine, modafinil, carisoprodol, and Xyrem.
Output: non-adverse drug event
Thus, further therapy must not be withheld.
Output: non-adverse drug event
Wolff Parkinson White (WPW) syndrome: what the critical care nurse needs to consider when administering antiarrhythmics.
Output: non-adverse drug event
The erythroid defect fully reversed after the drug was discontinued and could not be attributed to the patient's previously treated lung carcinoma.
Output: non-adverse drug event
Niemann-Pick type C is an autosomal-recessive, neurovisceral storage disorder that results from defective cholesterol esterification.
Output: non-adverse drug event
Prosthetic joint infection is an infrequent but serious complication of total joint arthroplasty.
Output: non-adverse drug event
The possible role of AK inhibition in these clinical responses requires further investigation.
Output: non-adverse drug event
Central nervous system imaging was negative.
Output: non-adverse drug event
Control hysterosalpingograms showed no tubal patency on the involved side.
Output: non-adverse drug event
The severity of the haemorrhagic diathesis prompted us to describe the case in order to draw the attention of medical personnel to the dangerous potentiation effects of different drugs administered with vitamin K antagonists.
Output: non-adverse drug event
CONCLUSION: If a parotid duct injury is diagnosed at the time of tumor extirpation, then surgical repair of the duct should be attempted, but if surgical repair is not possible or if an injury remains unrecognized until well after tumor extirpation, then surgery is not necessary.
Output: non-adverse drug event
S-1 is an oral 5-fluorouracil (5-FU) anticancer agent and has shown promising effects in the treatment of a wide range of carcinomas, including head and neck cancer.
Output: non-adverse drug event
The diagnosis of C. difficile was confirmed by a stool-cytotoxin test and endoscopic examination.
Output: non-adverse drug event
DISCUSSION: SIADH has been reported as a complication of treatment with vinca alkaloids.
Output: non-adverse drug event
Peritonsillar bupivacaine infiltration, a relatively safe method of pain control, is in some centers frequently used by otolaryngologists for pain relief.
Output: non-adverse drug event
The patient was initially treated for presumed bacterial peritonitis but remained febrile and had persistent abdominal pain and peritoneal fluid pleocytosis, despite broad-spectrum antibiotic therapy.
Output: non-adverse drug event
This report emphasizes the unnecessary hazard accompanying use of a potentially toxic drug-especially when prepared in error by the pharmacist-when a safer drug (nystatin) is available for treatment of oral candidiasis.
Output: non-adverse drug event
DISCUSSION: According to the literature, reversible nonthrombocytopenic palpable purpura has not been previously reported with metoclopramide.
Output: non-adverse drug event
RESULTS: In one patient the rifampin-impregnated shunt system was implanted after external drainage to prevent further infection.
Output: non-adverse drug event
Free SDCs were obtained using an ultrafiltration and fluorescence polarization immunoassay system in three patients over periods of up to 204 hours after Fab administration.
Output: non-adverse drug event
Photopatch tests to 1% mequitazine with 5 J/cm2 of UVA in 30 normal subjects were all negative, which means that 1% concentration may be appropriate for the photopatch test.
Output: non-adverse drug event
As with any new therapy, we suggest waiting for the results of a randomized, controlled trial before recommending this treatment.
Output: non-adverse drug event
Acromegaly increases the overall risk of neoplasms.
Output: non-adverse drug event
Pathophysiologic concerns have also been a key reason why physicians have avoided using beta-blockers in patients with diabetes.
Output: non-adverse drug event
METHODS: Case report.
Output: non-adverse drug event
All 3 patients experienced fairly typical chest pain syndromes and experienced elevations of cardiac enzymes consistent with myocardial ischemia.
Output: non-adverse drug event
CONCLUSION: We conclude that stanozolol is a safe and effective treatment of the cutaneous manifestations of cryofibrinogenemia.
Output: non-adverse drug event
We suggest the use of trihexyphenidyl in combination with isoprinosine in patients with subacute sclerosing panencephalitis with myoclonic seizures refractory to valproic acid.
Output: non-adverse drug event
A case of necrotizing fasciitis of the vulva arising in a leukemic patient during a chemotherapy nadir is presented.
Output: non-adverse drug event
In patients who show abnormal liver function tests, the immediate discontinuation of gliclazide is recommended.
Output: non-adverse drug event
To put this into perspective, total aplasia of red blood cells for 40 days would result in a drop of 30-33% in the red blood cell count.
Output: non-adverse drug event
The recognition, differential diagnosis, and management of this syndrome in children are discussed.
Output: non-adverse drug event
In rare patients, systemic absorption of inhaled tobramycin may be significant enough to produce toxic effects, such as renal and vestibular toxicities.
Output: non-adverse drug event
BACKGROUND: Tumor lysis syndrome (TLS) is rare in the treatment of solid tumors, but it may occur in myelolymphoproliferative diseases.
Output: non-adverse drug event
The patient was not obese.
Output: non-adverse drug event
PURPOSE: To report a new adverse effect related to treatment with bimatoprost.
Output: non-adverse drug event
As a result, we identified total 11 patients with nocturia and three of those completed the 12-week study of switching dopamine agonist from bromocriptine to pergolide.
Output: non-adverse drug event
Toxic streptococcal syndrome is characterized by fever, shock, multiorgan system failure and a desquamating scarlatiniform rash.
Output: non-adverse drug event
The administration of amyl nitrite and sodium thiosulfate led to a rapid improvement: the parameters reflecting oxygen metabolism improved and the plasma level of cyanide decreased.
Output: non-adverse drug event
The combination of levodopa and peripheral dopadecarboxylase inhibitor is the most efficacious symptomatic treatment for Parkinson's disease.
Output: non-adverse drug event
The response of the occlusion of nearly all liver venules underlines the value of anti-inflammatory treatment combined with new thrombolytic medication such as defibrotide for the treatment of severe VOD.
Output: non-adverse drug event
The reversible posterior leukoencephalopathy syndrome (RPLES) is a condition characterised by reversible neurological and radiological findings that has been associated with use of immunosuppressive, chemotherapeutic and more recently novel targeted therapies.
Output: non-adverse drug event
In our experience, the correct diagnosis and effective treatment at an early stage proved to be helpful to the patients in pulling out from the critical stage of acute radiation sickness.
Output: non-adverse drug event
Both reactions occurred late in the course of treatment.
Output: non-adverse drug event
A 600-mg loading dose appears to shorten the time to achieve an adequate antiplatelet effect to about two hours.
Output: non-adverse drug event
Disease behaviour in two patients was classified as penetrating because of concomitant ischiorectal abscesses, while one patient developed a metastatic colon carcinoma.
Output: non-adverse drug event
Bilateral computerized tomography showed no progression in radiographic changes during the treatment.
Output: non-adverse drug event
Spironolactone was continued, as serum creatinine and potassium levels were initially normal.
Output: non-adverse drug event
Clindamycin for treatment of Toxoplasma polymyositis in a dog.
Output: non-adverse drug event
A case of recurrent impetigo herpetiformis with a positive family history.
Output: non-adverse drug event
We present foreign body granulomas induced by activated charcoal from intraperitoneal chemotherapy and mimicked peritoneal metastases in the patients with gastric cancer.
Output: non-adverse drug event
Seven patients only smoked at night-time (median dose eight puffs, range two to eight puffs), and eight patients used cannabis mainly during the day (median dose three puffs, range two to eight puffs); the median frequency of use was four times per day (range one to 16 times per day).
Output: non-adverse drug event
METHODS: We describe the case of a 41-year-old male with HIV who received protease inhibitor medication and had neurologic deficits rapidly develop.
Output: non-adverse drug event
Radiological imaging revealed diffuse cortical necrosis.
Output: non-adverse drug event
Acute liver dysfunction complicated with uncontrollable glycemia due to insulin antibody: successful treatment with glucocorticoid and lispro insulin.
Output: non-adverse drug event
Antidepressants and myoclonus: case report.
Output: non-adverse drug event
Calciphylaxis (calcific uremic arteriolopathy) is a severe complication of hemodialysis characterized by subcutaneous calcification of the small arteries and tissue necrosis.
Output: non-adverse drug event
Two ajmaline tests were both negative and ruled out the diagnosis of BS.
Output: non-adverse drug event
We studied 13 healthy volunteer subjects, performing three hepatobiliary scans in each one.
Output: non-adverse drug event
To avoid that toxicity, a new weekly schedule has been adopted in several Phase II studies.
Output: non-adverse drug event
Cyproheptadine for intrathecal baclofen withdrawal.
Output: non-adverse drug event
The anti-epileptic agent trimethadione was given orally to 30 outpatients at a dose of 0.9-1.5 g daily.
Output: non-adverse drug event
Triptans are specific agonists of the serotonergic 5-HT(1B/1D) receptors that have increasingly been used in the treatment of migraine and cluster headaches.
Output: non-adverse drug event
In addition to the therapeutic benefits, prospective monitoring of free SDC in two of the patients also may have resulted in cost savings secondary to reduced hospital stay or less use of Fab.
Output: non-adverse drug event
We here report the first case of psoriatic arthritis which developed lung cancer.
Output: non-adverse drug event
Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.
Output: non-adverse drug event
Chylous ascites, a rare compliation following retroperitoneal lymph node dissection, has not been reported as a means of spread of testicular cancer.
Output: non-adverse drug event
Abdominal ultrasound was normal with the exception of a slight hepatomegaly without any lesions, focal or diffuse.
Output: non-adverse drug event
A manual pumping test is commonly used to verify the patency of a ventriculoperitoneal (V-P) shunt.
Output: non-adverse drug event
CONCLUSION: Our case shows a fatal side effect of erlotinib.
Output: non-adverse drug event
The advantages and disadvantages of uncontrolled case reports are reviewed using two cases of false-positive reactions to drugs as illustrative examples.
Output: non-adverse drug event
We review and summarize all reported cases of patients with ART-associated lactic acidosis reported in the English literature.
Output: non-adverse drug event
The ability of clozapine to suppress tardive dyskinesia symptoms raises the possibility that clozapine, at least at the doses used in this report, might also induce the disorder.
Output: non-adverse drug event
Taken together with other evidence that fluoroquinolones lower seizure threshold, this report suggests fluoroquinolones should be avoided in patients receiving ECT.
Output: non-adverse drug event
Acutely, SMS decreased acid secretion and restored the BAO/MAO to normal in eight of eight patients.
Output: non-adverse drug event
The exceeding of the solubility product of Ca(2+) and PO(4) (-) results in the precipitation of calcium phosphates.
Output: non-adverse drug event
After an interval of 3 months, he presented a complex pattern of nail hyperpigmentation, from combined dense horizontal and longitudinal streaks in some nails to diffuse black discoloration in others (Figure).
Output: non-adverse drug event
Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere.
Output: non-adverse drug event
Brain abscess following insertion of skull traction.
Output: non-adverse drug event
One 13-year-old boy with life-threatening systemic disease experienced a partial remission of disease and tolerated a decrease in prednisone dose from 15 to 4 mg daily following 14 exchanges with FFP.
Output: non-adverse drug event
Adalimumab in the management of palmoplantar psoriasis.
Output: non-adverse drug event
It must be considered as a potential source of cerebral hemorrhage in elderly patients undergoing thrombolysis for cardiac ischemia.
Output: non-adverse drug event
In the second patient, acute renal failure necessitated hemodialysis.
Output: non-adverse drug event
Patients should be informed of the risk of septic arthritis.
Output: non-adverse drug event
The case also highlights the increased cardiovascular morbidity in testicular cancer survivors and evokes the possibility of mechanisms of myocardial ischemia other than atherosclerotic disease in these young patients.
Output: non-adverse drug event
However, the patient later succumbed to her leukaemia.
Output: non-adverse drug event
A 10-year-old boy was diagnosed with ADHD and had received methylphenidate hydrochloride, 60 mg/day for 2 years.
Output: non-adverse drug event
Hydroxyzine alone caused an insignificant delay.
Output: non-adverse drug event
The potential for absorption is not well described in patients with impaired gastrointestinal (GI) mucosa.
Output: non-adverse drug event
She developed a febrile illness associated with severe pancytopenia and leukocytoclastic vasculitic rash followed by diffuse adenopathy, with serologic and pathologic evidence of EBV infection.
Output: non-adverse drug event
PCR analysis showed CMV-DNA in the failed graft.
Output: non-adverse drug event
The conditions treated were: Hodgkin's disease (four patients), primary amyloidosis, primary macroglobulinemia, malignant lymphoma, multiple myeloma, and carcinoma of the tonsil.
Output: non-adverse drug event
Two had positive antihistone antibodies.
Output: non-adverse drug event
Concurrent use of reteplase and lepirudin in the treatment of acute anterior wall myocardial infarction.
Output: non-adverse drug event
This deterioration started 3 months post-treatment and worsened over the ensuing 4 years.
Output: non-adverse drug event
For 9 years the patient remained totally asymptomatic.
Output: non-adverse drug event
RESULTS: The mean age and duration of illness of the patients were 38.93+/-8.36 and 12.88+/-6.90 years, respectively.
Output: non-adverse drug event
We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin.
Output: non-adverse drug event
Documentation of adverse events for safe and commonly used drugs is important.
Output: non-adverse drug event
After prolonged recovery periods, only mild neurological deficits persisted in both patients.
Output: non-adverse drug event
Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature.
Output: non-adverse drug event
The patient was regularly taking a mixture of herbal products, used as a laxative, for a number of years, with no alteration of blood chemistry until 6 months before the present observation.
Output: non-adverse drug event
BACKGROUND: Recombinant activated factor VII (rFVIIa), originally developed for the treatment of life-threatening bleeding in hemophilic patients with inhibitors to factors VIII or IX, has been increasingly used to control hemorrhage unresponsive to conventional treatment, in the absence of a defined coagulopathy or thrombocytopathy.
Output: non-adverse drug event
MATERIALS AND METHODS: Two dialysis patients with recently rejected renal allografts who were hospitalized because of fever of unknown origin are reported.
Output: non-adverse drug event
Ultrastructurally the follicular cells contained large residual bodies composed of abundant electron-lucent lipid droplets of variable size.
Output: non-adverse drug event
After unsuccessful fluid resuscitation with crystalloid fluid, the patient's condition improved rapidly with human albumin boluses.
Output: non-adverse drug event
Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Output: non-adverse drug event
Nosocomial malaria and saline flush.
Output: non-adverse drug event
Dopamine agonists are increasingly used in the treatment of Parkinson disease, but they may cause serious adverse effects.
Output: non-adverse drug event
Before starting Zoledronic acid therapy, the patient's serum calcium level was 6.9 mg/dl.
Output: non-adverse drug event
A case is presented in which amiodarone was administered to suppress paroxysmal atrial fibrillation in a patient with an idiopathic cardiomyopathy.
Output: non-adverse drug event
PDT was performed twice, but after the second cycle, patient developed choroidal ischemia and the visual outcomes were poor.
Output: non-adverse drug event
The second is a case of superficial invasion of Candida in a stitch ulcer.
Output: non-adverse drug event
Subsequently, the patient presented with a lower eyelid mass, which on excision was demonstrated to be a chalazion.
Output: non-adverse drug event
The mortality rate has been estimated at about 10%.
Output: non-adverse drug event
A 33-year-old man with advanced testicular cancer underwent high-dose chemotherapy combined with peripheral blood stem cell transplantation.
Output: non-adverse drug event
The mechanism of the interaction is probably inhibition of glipizide metabolism rather than protein-binding displacement.
Output: non-adverse drug event
Sometimes the presentation is with diabetic ketoacidosis, requiring insulin treatment, which can nevertheless be reversible.
Output: non-adverse drug event
All patients except two had new recurrences within the observation time.
Output: non-adverse drug event
Many new serotonergic antidepressants have been introduced over the past decade.
Output: non-adverse drug event
The response to chemotherapy was not satisfactory.
Output: non-adverse drug event
Liver biopsy disclosed submassive hepatic necrosis.
Output: non-adverse drug event
RESULTS: Complete thrombosis of the mycotic aneurysms was achieved in all patients.
Output: non-adverse drug event
The reactive process included an infiltrative superficial dermatitis and a mural folliculitis with prevalent participation of macrophages and lymphocytes.
Output: non-adverse drug event
Photochemotherapy using psoralen and ultraviolet (UV)A irradiation (PUVA) is a useful treatment method for vitiligo.
Output: non-adverse drug event
This case and the brief review of the literature which follows emphasize the danger of prednisone administration in patients who have asthma and a history of drug intolerance.
Output: non-adverse drug event
Two cases, one of leukemia and one of a trophoblastic testicular teratoma, are described in which hypoglycemia occurred as a terminal event.
Output: non-adverse drug event
Autopsy demonstrated extensive necrosis of the tumor mass, as well as necrotizing vascular damage within the neoplasm.
Output: non-adverse drug event
Clinical and chemical improvement was observed in the majority of subjects but normal 24-hour serum growth hormone levels were achieved in no more than 35 percent of this group and possibly less.
Output: non-adverse drug event
Cessation of MTX therapy led to complete regression of the tumor.
Output: non-adverse drug event
DESIGN: Description of the clinical findings in two patients with this condition.
Output: non-adverse drug event
Drug-induced ocular pemphigoid has been reported to occur after long-term use of topical glaucoma medications.
Output: non-adverse drug event
Further study revealed that all three patients had low plasma renin activity and nonsuppresible plasma aldosterone levels after saline infusion.
Output: non-adverse drug event
METHODS: Tissue obtained during vitrectomy was cultured and examined by light and electron microscopy.
Output: non-adverse drug event
Side effects associated with this medication are usually minor; serious complications are most often due to the delivery system required for continuous infusion.
Output: non-adverse drug event
Cutaneous biopsy showed hyphae and round inclusions stained with PAS and Gomori-Grocott within a polymorphous granuloma.
Output: non-adverse drug event
After previously tolerating ECT well, introduction of moxifloxacin for a respiratory tract infection was associated with prolonged seizure duration despite complete resolution of her respiratory complaint.
Output: non-adverse drug event
Continuing the treatment with 13-cis-retinoic acid without systemic steroid eventually cleared the systemic manifestations and skin lesions.
Output: non-adverse drug event
One patient died suddenly during an exchange with FFP; the cause of death appeared related to microemboli of unknown nature found in the lungs at autopsy.
Output: non-adverse drug event
Iron was absent.
Output: non-adverse drug event
Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma.
Output: non-adverse drug event
Traditional neuroleptics have been the mainstay of treatment for agitated behavior in persons with dementia, but these agents have limited efficacy and are associated with high rates of adverse effects, including worsening of already poor cognitive functioning.
Output: non-adverse drug event
Four cases involving men with New York Heart Association functional class III heart failure are presented.
Output: non-adverse drug event
CONCLUSIONS: Complications concerning a primary perforation of the bladder and instillation of chemotherapeutic drugs can be easily avoided by recognising the perforation intraoperatively.
Output: non-adverse drug event
A neuroprotective and neuroregenerative treatment attempt with pyridoxine and pyridostigmine was initiated.
Output: non-adverse drug event
Care providers who refill pump reservoirs with morphine must be knowledgeable about these devices and the life-threatening consequences associated with errors in refilling them.
Output: non-adverse drug event
After a latent period of 4 months, he developed a progressive, severe and ultimately fatal radiation myelopathy, which we suggest was due to a synergistic interaction between the high-dose chemotherapy and the radiotherapy.
Output: non-adverse drug event
Recommendations that may help prevent these adverse systemic effects in premature infants include: (1) avoidance of excess subconjunctival anesthetic doses, (2) preoperative administration of systemic atropine to minimize the oculocardiac reflex, (3) consideration of an analgesic agent to decrease the pain and exhaustion, and (4) cardiorespiratory monitoring in a hospital setting, with an intravenous line in place, at the time of treatment.
Output: non-adverse drug event
The concentration of pseudoephedrine in blood and liver specimens was measured using gas chromatography-mass spectrometry and was determined to be 14.4 mg/L in the blood and 16 mg/kg in the liver.
Output: non-adverse drug event
Scapular upward rotation is predominantly achieved via a force coupling involving the upper and lower trapezius and the serratus anterior.
Output: non-adverse drug event
Some cases run a chronic severe course and fail to respond to local and systemic therapy.
Output: non-adverse drug event
KS is a rare complication in glomerular diseases that may (or may not) be related to immunosuppression.
Output: non-adverse drug event
Although HCV-RNA reappeared in the serum at 3 months, the patient had continued ALT normalization and histological improvement with follow-up of over 26 months to date after the initiation of the combination therapy.
Output: non-adverse drug event
Flavimonas oryzihabitans (CDC group Ve-2) bacteraemia associated with Hickman catheters.
Output: non-adverse drug event
CONCLUSIONS: The results of our study suggest that the pharmacokinetics of parent ifosfamide may not be substantially altered in patients with renal failure.
Output: non-adverse drug event
A stage Va B-cell multicentric lymphoma was diagnosed on clinical, cytological (lymph node, bone marrow), histological-immunohistochemical (lymph node excision) and imaging grounds.
Output: non-adverse drug event
Infected graft transplantation is an unwelcome complication that may lead to serious consequences in the immunosuppressed host.
Output: non-adverse drug event
A case of hepatocellular carcinoma in a young female is presented in which the apparent etiology was the use of oral contraceptives for 5 1/2 years.
Output: non-adverse drug event
Three patients with T315I abl-mutated chronic myeloid leukemia (CML) or Philadelphia chromosome (Ph)-positive acute lymphocytic leukemia (ALL) have achieved clinical responses to doses of MK-04547 that are not associated with adverse events.
Output: non-adverse drug event
Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir.
Output: non-adverse drug event
Ten months after the injection, visual acuity remained at 20/50, and intraocular pressure measured 15 mm Hg without antiglaucomatous therapy taken.
Output: non-adverse drug event
His obstruction resolved, and he remains well at 11 months.
Output: non-adverse drug event
As NBD-Cl has not been reported as an allergen before, the characteristics of this chemical and its use as an analytical reagent are briefly surveyed.
Output: non-adverse drug event
In one case the growth rate and cortisol response returned to normal 9 months after the fluticasone dose was reduced to 500 micrograms/day.
Output: non-adverse drug event
In two patients, adenosine precipitated acceleration of ventricular response, in one case necessitating emergent cardioversion.
Output: non-adverse drug event
His symptoms included bradycardia, hypotension, hypothermia, pallor, cyanosis, and impaired consciousness.
Output: non-adverse drug event
In one 12-month period he had 88 separate admissions to an emergency department with severe hypoglycaemic coma requiring intravenous glucose administration.
Output: non-adverse drug event
Two of these cases concerned relatively young, previously healthy patients and had fatal outcomes.
Output: non-adverse drug event
Three cases are described in which periorbital topical corticosteroids appear to have resulted in raised intraocular pressure or glaucoma.
Output: non-adverse drug event
Four of the aviators were allowed to continue on active duty with limitations and one was disqualified.
Output: non-adverse drug event
In this article, four patient reports of a specific interaction--the serotonin syndrome--are presented.
Output: non-adverse drug event
Results of coronary investigations were negative.
Output: non-adverse drug event
The pertinent literature on ergotism is reviewed, and it is emphasized that ergotism may develop in patients on therapeutic doses of the drug.
Output: non-adverse drug event
History revealed that the patient had taken a combination phenolphthalein/docusate sodium (Correctol) over-the-counter laxative 1 day prior to admission.
Output: non-adverse drug event
Hemoglobin electrophoresis and methemoglobin reductase determinations were normal for age.
Output: non-adverse drug event
The regimen was based on conditioning experiments with animals who had lupuslike autoimmune disease.
Output: non-adverse drug event
Conspicuous endoscopic appearance of ventriculitis caused by coagulase-negative staphylococci.
Output: non-adverse drug event
High doses of atropine (up to 50 mg per 24 hours), adrenaline and dopamine were necessary.
Output: non-adverse drug event
Anticoagulant therapy was initiated with subcutaneous enoxaparin and oral warfarin.
Output: non-adverse drug event
Overnight sleep studies and multiple sleep latency testing were carried out under double-blind administration of either L-dopa or placebo.
Output: non-adverse drug event
This was initially diagnosed as a spreading dental infection.
Output: non-adverse drug event
The patient subsequently responded well to intravenous antibiotics, intravenous corticosteroids, and local wound care.
Output: non-adverse drug event
To the authors' knowledge, this is the first report in the English-language literature of spontaneous neonatal intracerebral hemorrhage, due to thrombosis of the superior or inferior vena cava.
Output: non-adverse drug event
Evaluation revealed CMV viremia with a high viral load and CMV gastritis was confirmed using gastroscopy and histopathologic examination.
Output: non-adverse drug event
Intradiscal injection of triamcinolone hexacetonide for acute, subacute, and chronic sciatica.
Output: non-adverse drug event
Symptomatic air trapped in the spine after lumbar epidural corticosteroid injection.
Output: non-adverse drug event
The authors describe two patients with this disease who initially had findings suggestive of an optic neuropathy.
Output: non-adverse drug event
These children aged 2.5-15 years were treated for Burkitt's lymphoma, Ewing's tumour, small cell bone tumour or medulloblastoma.
Output: non-adverse drug event
This is the first case of PML after SCT treated with cidofovir, and the fifth case treated with this drug in a patient without human immunodeficiency virus (HIV) infection.
Output: non-adverse drug event
Lamotrigine clearance increases throughout pregnancy, and maternal dose increases are often necessary to maintain therapeutic effect.
Output: non-adverse drug event
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
Output: non-adverse drug event
Because of its favorable tolerability profile it appears to be a preferred alternative, especially in NSAID-sensitive patients.
Output: non-adverse drug event
A 57-year-old woman with end-stage renal disease presumed secondary to chronic glomerulonephritis underwent a living related renal allograft transplantation.
Output: non-adverse drug event
We report the case of a 54-year old man with decompensated alcoholic liver cirrhosis and HIV infection who underwent liver transplantation (LT).
Output: non-adverse drug event
Food and Drug Administration in 1989 for treatment of severely ill schizophrenic patients.
Output: non-adverse drug event
In turn, it may cause inflammation in such rapidly dividing tissues as the corneal epithelium, conjunctiva, and tear duct.
Output: non-adverse drug event
The patient's platelet count dropped rapidly to a level of 1000/mm3 after receiving a single 600 mg dose of rifampin.
Output: non-adverse drug event
PURPOSE: To describe a case of progressive outer retinal necrosis in a human immunodeficiency virus-negative immunosuppressed patient undergoing treatment for graft-versus-host disease after bone marrow transplantation.
Output: non-adverse drug event
MAIN OUTCOME MEASURES: Clinical signs and symptoms of ITB withdrawal of varying severity were assessed by vital signs (temperature, heart rate), physical examination (reflexes, tone, clonus), and patient report of symptoms (itching, nausea, headache, malaise).
Output: non-adverse drug event
Our report points out differences between acute, postacute, and longterm rehabilitation, describes the mobilization of patients in acute rheumatology units, and defines specific problems encountered in acute hospital-based rehabilitation of rheumatological patients.
Output: non-adverse drug event
It gives the radiological and CT scan findings and the important role played by them in the diagnosis of this syndrome.
Output: non-adverse drug event
METHODS: Prospective, interventional, single case report.
Output: non-adverse drug event
Nineteen months after diagnosis, her mother gave birth to an HLA-compatible sibling, whose cord blood was cryopreserved.
Output: non-adverse drug event
BACKGROUND: In the 1940s and '50s the first oral hypoglycaemic agents (the sulphonylureas and metformin) became available.
Output: non-adverse drug event
Immunofluorescent study showed granular deposits of IgG and C3 complement along glomerular basement membranes.
Output: non-adverse drug event
EEG was abnormal and somatosensory-evoked potentials (SEPs) showed giant SEPs, transcortical reflex (C reflex) and jerk locked potentials.
Output: non-adverse drug event
None of these patients experienced a relapse of their PTLD with follow-up ranging from 1.5 to 5 years.
Output: non-adverse drug event
Nitric oxide, a potent smooth muscle relaxant, has been shown to be involved in the initiation and maintenance of erections; future research involving specific inhibitors of this chemical is indicated for the possible treatment of intraoperative penile erections.
Output: non-adverse drug event
One patient received moxalactam as part of the combination therapy for diffuse pulmonary infiltration during renal transplant rejection.
Output: non-adverse drug event
Malpractice litigation was brought about because the patient alleged that he had steroid cataracts, which resulted from his having received systemic corticosteroids.
Output: non-adverse drug event
The condition is primarily reported in patients with end-stage renal disease, and is associated with significant morbidity and mortality.
Output: non-adverse drug event
BACKGROUND: Most of the new fillers used for soft tissue augmentation in aesthetic dermatology are considered well tolerated, but very little data are available on their long-term tolerability, especially in patients receiving immunomodulatory therapy.
Output: non-adverse drug event
Addition of lithium carbonate resulted in a sustained remission with maintenance treatments.
Output: non-adverse drug event
It is a potentially serious reaction which is little influenced by which drug is injected.
Output: non-adverse drug event
Because a catheter-related infection was suspected, the Port-A-Cath was removed after a 10-day course of piperacillin-tazobactam.
Output: non-adverse drug event
The degree of emanating clinical events also conforms to status of the aflatoxicosis.
Output: non-adverse drug event
Little inflammatory change was noted in either the epithelial or stromal layers of the failed graft.
Output: non-adverse drug event
Medication can induce severe ulcerations.
Output: non-adverse drug event
After rapid correction of severe hyponatremia, a 36-year-old man developed osmotic demyelination syndrome (ODS), manifested neurologically by impaired cognition, extremity weakness, bilateral third cranial nerve palsies, and gaze-evoked upbeat and rotary nystagmus.
Output: non-adverse drug event
With increasing administration of acetylcholinesterase inhibitors for patients with Alzheimer's disease, practitioners should be aware of the potential for drug-drug interactions and other complications.
Output: non-adverse drug event
Evaluation of hypothermia with psychiatric patients should include primary accidental hypothermia, central nervous system disorders, metabolic disorders, infections, and medications.
Output: non-adverse drug event
Tigecycline is a broad-spectrum antimicrobial agent structurally related to minocycline.
Output: non-adverse drug event
Clofibrate has been considered to be a relatively safe antidiuretic in the treatment of diabetes insipidus.
Output: non-adverse drug event
During this period, urine losses of monovalent cation were only 55 mEq and body weight was constant at 48.2 kg.
Output: non-adverse drug event
Case study on drug-related adverse effects of hepatitis C therapy.
Output: non-adverse drug event
Bacteremia due to Enterococcus avium.
Output: non-adverse drug event
Patients were followed with sequential ocular examinations for a maximum of 36 weeks.
Output: non-adverse drug event
Severe rhabdomyolysis developed within 5 hours after the injection.
Output: non-adverse drug event
The diabetes improved when the treatment was discontinued and worsened on re-introduction.
Output: non-adverse drug event
The clinical and histologic presentation of this side effect and possible biochemical mechanisms of pathogenesis are discussed.
Output: non-adverse drug event
The addition of certain substrates such as glutamine, arginine and omega-3 fatty acids may improve the body's immune response as well.
Output: non-adverse drug event
Report of a case.
Output: non-adverse drug event
Although this condition occurs primarily in severely myelosuppressed and immunosuppressed patients with leukemia, it may also occur in those with other advanced malignancies receiving myelosuppressive chemotherapy.
Output: non-adverse drug event
The diagnostic pitfalls are discussed with the case, and the need for careful interpretation of laboratory findings in conjunction with clinical signs is emphasized.
Output: non-adverse drug event
Topiramate may be a treatment option in CPH.
Output: non-adverse drug event
TREATMENT AND OUTCOME: Exploratory surgery of the coelomic cavity was performed and the neoplasm was excised.
Output: non-adverse drug event
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic syndromes.
Output: non-adverse drug event
INTRODUCTION: Despite high success rates with free-tissue transfer, flap loss continues to be a devastating event.
Output: non-adverse drug event
Brain MRI revealed lesions in the thalamus and the brainstem, particularly the tegmentum, and the basis pontis in addition to the basal ganglion lesions.
Output: non-adverse drug event
Using a medical emergency team to manage anaphylactic shock.
Output: non-adverse drug event
Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls.
Output: non-adverse drug event
Following prompt recognition and diagnosis, intravenous thrombolytic therapy was administered 2 hours after symptom onset.
Output: non-adverse drug event
Following steroid withdrawal and institution of gammaglobulin, the patient grew 6 inches within 2 years, regaining his vision, retrieving his stature, and normalizing his psychosocial development.
Output: non-adverse drug event
SETTING: Hospital-based pathology laboratory processing inpatient and outpatient specimens.
Output: non-adverse drug event
There were four females, 20 males, with 19 patients under the age of 18 years and five over the age of 18.
Output: non-adverse drug event
The two patients were successfully treated with pharmacological thrombolysis with no recurrence.
Output: non-adverse drug event
Intravenous valproate has been suggested for the treatment of status epilepticus in part because of its relatively good cardiovascular safety profile.
Output: non-adverse drug event
Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis.
Output: non-adverse drug event
As the disfiguring lesions had a marked adverse effect on her quality of life, a trial of IV Cidofovir was instituted.
Output: non-adverse drug event
Somatostatin can be helpful after liver transplantation in some well-defined indications.
Output: non-adverse drug event
The patient's lymphocytes showed no proliferative response to zomepirac.
Output: non-adverse drug event
Primary pneumococcal peritonitis complicated by exudative pleural effusion in an adolescent girl.
Output: non-adverse drug event
Coagulation parameters of 3 different time-points were assessed and compared: before administration of any blood product (time-point 1), before administration of the first dose of rFVIIa (time-point 2), and 4 hours after the administration of the last dose of rFVIIa (time-point 3).
Output: non-adverse drug event
Inadvertent substitution of acetohexamide for acetozolamide.
Output: non-adverse drug event
We know of no other reported cases of spontaneous muscle necrosis in association with diabetes insipidus and feel that there should be increased awareness of the association between the two.
Output: non-adverse drug event
Following, we performed a double-blind oral challenge test with drugs who results was negative.
Output: non-adverse drug event
The patient responded to atovaquone plus proguanil followed by primaquine.
Output: non-adverse drug event
By a combination of appropriate selection of medications and an awareness of delirium as a side effect, the patient in the ICU may be treated in a manner to minimize the clouding of consciousness.
Output: non-adverse drug event
DISCUSSION: The severity and presentation of central nervous system toxicity due to ifosfamide varies greatly and involves a spectrum ranging from subclinical electroencephalogram changes to coma.
Output: non-adverse drug event
Possible relationships between the white matter lesions and extrinsic toxic agents are discussed.
Output: non-adverse drug event
Diffuse, reversible arterial irregularities consistent with vasospasm were present on MRA during the acute illness.
Output: non-adverse drug event